Health and Healthcare

Teva : TEVA

All Teva Articles

450 Articles

Chris Lange | Nov 11, 2015 at 8:15 AM EST

Short Sellers Continue to Decrease Bets in Major Pharma

The short interest data have been released for the October 30 settlement date, and for most of the selected pharmaceutical…

Lee Jackson | Nov 3, 2015 at 10:35 AM EST

Jefferies Top Large Cap Value Stocks to Buy for This Week

It is the best of both worlds for investors when large cap growth companies become inexpensive enough to have a…

Lee Jackson | Oct 28, 2015 at 10:35 AM EDT

With Specialty Pharmaceuticals Down Big, 3 to Buy Now for Huge Potential Gains

With specialty pharmaceutical stocks having the chance to move dramatically higher, three large cap leaders are RBC's favorites now.

Chris Lange | Oct 27, 2015 at 9:05 AM EDT

Short Sellers Have Mixed Views on Major Pharma

The October 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Chris Lange | Oct 12, 2015 at 9:25 AM EDT

Short Sellers Become More Selective on Major Pharma

The September 30 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Trey Thoelcke | Oct 9, 2015 at 7:05 AM EDT

Generics Giants Like Teva and Mylan May Now Join the Buy-and-Raise Craze

Martin Shkreli has said he would lower the price of Daraprim back down but hasn’t actually done it. He probably…

Chris Lange | Sep 25, 2015 at 8:40 AM EDT

Short Sellers Boost Positions in Major Pharma

The September 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Chris Lange | Sep 11, 2015 at 8:25 AM EDT

Short Sellers Become More Selective in Major Pharma

The short interest data have been released for the August 31 settlement date, and for the selected pharmaceutical stocks, short…

Chris Lange | Aug 26, 2015 at 8:05 AM EDT

Short Sellers Have Mixed Feelings on Major Pharma

The August 14 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short…

Trey Thoelcke | Aug 13, 2015 at 10:50 AM EDT

4 More Recession Stocks to Consider for Volatile Times

Stocks toward the cheap consumption end of the economy tend to do better than capital goods stocks dependent on low…

Chris Lange | Aug 12, 2015 at 9:45 AM EDT

Short Sellers Back Off Big Pharma

The short interest data have been released for the July 31 settlement date, and for most of the selected pharmaceutical…

Jon C. Ogg | Jul 31, 2015 at 1:44 PM EDT

Teva Proves Its Decade-Hold Status With Massive Funding

ThinkstockTeva Pharmaceutical Industries Ltd. (NYSE: TEVA) may have just proved how financially fit and capable the company is. On Friday…

Chris Lange | Jul 30, 2015 at 9:13 AM EDT

Are Teva Earnings Enough?

ThinkstockTeva Pharmaceutical Industries Limited (NYSE: TEVA) reported its second-quarter financial results Thursday before the markets opened. The company had $1.43…

Jon C. Ogg | Jul 28, 2015 at 8:26 AM EDT

Top Analyst Upgrades and Downgrades: Baidu, BlackBerry, GM, PayPal, Teva, Yelp and Many More

Jon OggStocks were indicated higher on Tuesday morning after 5 days in a row of selling. Yet again we see…

Chris Lange | Jul 27, 2015 at 8:21 AM EDT

Short Sellers Run For Cover From Major Pharma

ThinkstockThe short interest data have been released for the July 15 settlement date. Pharmaceutical companies are usually involved in a…

1 … 18 19 20 21 22 … 30

Teva : TEVA

All Teva Articles

Short Sellers Continue to Decrease Bets in Major Pharma

Jefferies Top Large Cap Value Stocks to Buy for This Week

With Specialty Pharmaceuticals Down Big, 3 to Buy Now for Huge Potential Gains

Short Sellers Have Mixed Views on Major Pharma

Short Sellers Become More Selective on Major Pharma

Generics Giants Like Teva and Mylan May Now Join the Buy-and-Raise Craze

Short Sellers Boost Positions in Major Pharma

Short Sellers Become More Selective in Major Pharma

Short Sellers Have Mixed Feelings on Major Pharma

4 More Recession Stocks to Consider for Volatile Times

Short Sellers Back Off Big Pharma

Teva Proves Its Decade-Hold Status With Massive Funding

Are Teva Earnings Enough?

Top Analyst Upgrades and Downgrades: Baidu, BlackBerry, GM, PayPal, Teva, Yelp and Many More

Short Sellers Run For Cover From Major Pharma

‘Traders Need to Be Really Careful Here’: Schwab on the Fed Decision and Powell’s Uncertain Future

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

This Dividend ETF Is up 30% in 6 Months With a 3.7% Dividend Yield

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Long-Term Care Could Cost This 68-Year-Old Couple $380,000 and Their $2.1 Million Portfolio Is Not Structured for It

‘Traders Need to Be Really Careful Here’: Schwab on the Fed Decision and Powell’s Uncertain Future

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Teva : TEVA

All Teva Articles

Short Sellers Continue to Decrease Bets in Major Pharma

Jefferies Top Large Cap Value Stocks to Buy for This Week

With Specialty Pharmaceuticals Down Big, 3 to Buy Now for Huge Potential Gains

Short Sellers Have Mixed Views on Major Pharma

Short Sellers Become More Selective on Major Pharma

Generics Giants Like Teva and Mylan May Now Join the Buy-and-Raise Craze

Short Sellers Boost Positions in Major Pharma

Short Sellers Become More Selective in Major Pharma

Short Sellers Have Mixed Feelings on Major Pharma

4 More Recession Stocks to Consider for Volatile Times

Short Sellers Back Off Big Pharma

Teva Proves Its Decade-Hold Status With Massive Funding

Are Teva Earnings Enough?

Top Analyst Upgrades and Downgrades: Baidu, BlackBerry, GM, PayPal, Teva, Yelp and Many More

Short Sellers Run For Cover From Major Pharma

‘Traders Need to Be Really Careful Here’: Schwab on the Fed Decision and Powell’s Uncertain Future

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

This Dividend ETF Is up 30% in 6 Months With a 3.7% Dividend Yield

Featured Reads

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Long-Term Care Could Cost This 68-Year-Old Couple $380,000 and Their $2.1 Million Portfolio Is Not Structured for It